To access this element change to forms mode OFF
Grant Award View - GA268547
eVidence synthesis to inform the optimAL UsE of Immunoglobulin (The...
GA ID:
GA268547
Agency:
Department of Health and Aged Care
Approval Date:
7-Apr-2022
Publish Date:
4-Oct-2022
Category:
Medical Research
Grant Term:
7-Apr-2022 to 31-Mar-2025
Value (AUD):
$1,723,772.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
eVidence synthesis to inform the optimAL UsE of Immunoglobulin (The VALUE-Ig Study)
Purpose:
Immunoglobulin (Ig) therapy can be effective at preventing infections or controlling immune system response. However, there is weak evidence to guide treatment decisions such as who should receive Ig and how long they should stay on Ig? This project will use health data on Australian Ig therapy patients to ensure Ig is used judiciously to avoid wasted valuable resources but always available to those patients for whom it provides a cost-effective benefit.
GO ID:
GO Title:
MRFF – PPHRI – 2021 Optimising the Clinical Use of Immunoglobulins Grant Opportunity
Internal Reference ID:
2022/MRF2017480
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC
Postcode:
Multiple
Country:
AUSTRALIA